PMID- 1512223 OWN - NLM STAT- MEDLINE DCOM- 19920925 LR - 20210210 IS - 0021-9258 (Print) IS - 0021-9258 (Linking) VI - 267 IP - 24 DP - 1992 Aug 25 TI - Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen. PG - 16812-5 AB - Two different types of macrophage colony-stimulating factors (M-CSF) were found, one with an apparent molecular mass of 85 kDa and the other greater than 200 kDa. The high molecular mass M-CSF was identified as a proteoglycan carrying chondroitin sulfate glycosaminoglycan and was designated as the proteoglycan form of M-CSF (PG-M-CSF). In this study, we compared the biological activity of the 85-kDa M-CSF and PG-M-CSF and examined the binding properties of these two M-CSF to certain extracellular matrix proteins, i.e. types I-V collagen and fibronectin, using a modified enzyme-linked immunosorbent assay. PG-M-CSF was capable of supporting the formation of murine macrophage colonies, and pretreatment of PG-M-CSF with chondroitinase AC, which degrades chondroitin sulfate, did not alter its colony-stimulating activity. The specific activity of PG-M-CSF was similar to that of the 85-kDa M-CSF. The 85-kDa M-CSF had no apparent affinity for the extracellular matrix proteins examined, whereas PG-M-CSF had an appreciable binding capacity to type V collagen, but did not bind to types I, II, III, and IV collagen or to fibronectin. Pretreatment of PG-M-CSF with chondroitinase AC completely abolished the binding of the species to type V collagen. Addition of exogenous chondroitin sulfate inhibited the binding of PG-M-CSF to type V collagen in a dose-dependent manner. These data indicated that the interaction between PG-M-CSF and type V collagen was mediated by the chondroitin sulfate chain of PG-M-CSF. PG-M-CSF bound to type V collagen could stimulate the proliferation of bone marrow macrophages, indicating that the matrix protein-bound PG-M-CSF retained its biological activity. This interaction between PG-M-CSF and type V collagen implies that the role of PG-M-CSF may be distinct from that of 85-kDa M-CSF. FAU - Suzu, S AU - Suzu S AD - Biochemical Research Laboratory, Morinaga Milk Industry Co, Ltd., Kanagawa, Japan. FAU - Ohtsuki, T AU - Ohtsuki T FAU - Makishima, M AU - Makishima M FAU - Yanai, N AU - Yanai N FAU - Kawashima, T AU - Kawashima T FAU - Nagata, N AU - Nagata N FAU - Motoyoshi, K AU - Motoyoshi K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Biol Chem JT - The Journal of biological chemistry JID - 2985121R RN - 0 (Proteoglycans) RN - 0 (Recombinant Proteins) RN - 81627-83-0 (Macrophage Colony-Stimulating Factor) RN - 9007-34-5 (Collagen) SB - IM MH - Animals MH - Bone Marrow Cells MH - CHO Cells MH - Cell Division/drug effects MH - Cells, Cultured MH - Collagen/*metabolism MH - Cricetinae MH - Enzyme-Linked Immunosorbent Assay MH - Kinetics MH - Macrophage Colony-Stimulating Factor/*metabolism/*pharmacology MH - Macrophages/*cytology/drug effects MH - Mice MH - Mice, Inbred C57BL MH - Proteoglycans/*metabolism/pharmacology MH - Recombinant Proteins/pharmacology MH - Swine EDAT- 1992/08/25 00:00 MHDA- 1992/08/25 00:01 CRDT- 1992/08/25 00:00 PHST- 1992/08/25 00:00 [pubmed] PHST- 1992/08/25 00:01 [medline] PHST- 1992/08/25 00:00 [entrez] AID - S0021-9258(18)41855-8 [pii] PST - ppublish SO - J Biol Chem. 1992 Aug 25;267(24):16812-5.